VRXA Veraxa Biotech AG
Company Analysis
Latest News
🟢 Veraxa Biotech is trading 5.65% up today; catalyst remains unclear
Veraxa Biotech is trading 5.65% up at $1.68, though the catalyst remains unclear. - No clear company-specific announcement dated September 10, 2026, was...
🔴 Veraxa Biotech is trading 10.23% down today after likely profit-taking
Veraxa Biotech is trading at $1.58, down 10.23%, as likely profit-taking follows its sharp multi-session advance. - Shares rose 15.03% to $1.76 on September 4...
🔴 Veraxa Biotech is trading 6.25% down today amid likely profit-taking
Veraxa Biotech is trading 6.25% down at $1.65, pressured by softer broader-market sentiment and likely profit-taking after a sharp multi-session rally. -...
🔴 Veraxa Biotech is trading 5.9% down in pre-market following a sharp rally during prior sessions
Veraxa Biotech is trading at $1.66 (-5.93%) after a sharp rally during prior sessions. - The stock declined from the $1.76 September 7 close. - No new...
🟢 Veraxa Biotech is trading 13.07% up today after appointing Raju Willener as CFO
Veraxa Biotech is trading 13.07% up at $1.73 after appointing Raju Willener as chief financial officer, effective September 4, 2026. - He succeeds Carl von...
Veraxa Biotech Swaps CFOs and Stock Jumps 23% in a Week — Can a New Finance Chief Revive a Sub-$2 Stock?
Shares of Veraxa Biotech AG shifted sharply upward as the Swiss clinical-stage biotech installed Raju Willener as its new Chief Financial Officer, effective...
🟢 Veraxa Biotech is trading 8.5% up today after immediate appointment of Raju Willener as CFO
Veraxa Biotech is trading 8.5% up at $1.66 after announcing Raju Willener’s immediate CFO appointment on September 4, 2026. - Willener brings more than 30...
🟢 Veraxa Biotech is trading 12.3% up today as XBI gains 2.75%
Veraxa Biotech is trading at $1.55, up 12.32%, amid stronger biotech sector sentiment rather than a confirmed company-specific catalyst. - XBI is up 2.75%,...
🟢 Veraxa Biotech is trading 5.4% up today amid patent-related enthusiasm
Veraxa Biotech is trading at $1.46, up +5.43% on September 3, 2026, amid patent-related enthusiasm and improving biotechnology sentiment. - The biotech sector...
🟢 Veraxa Biotech is trading 14.27% up today — isolated rebound without a clear catalyst
Veraxa Biotech is trading 14.27% up now at $1.54, rebounding after several consecutive declines. - Shares fell from $1.95 on August 21, 2026, to $1.35 on...
🟢 Veraxa Biotech is trading 8.89% up today after several consecutive declines
Veraxa Biotech is trading 8.89% up at $1.47, following several consecutive declines. - Closing price fell from $1.95 to $1.35 between August 21–31. - No clear...
🔴 Veraxa Biotech is trading 5.56% down today — no company-specific catalyst identified
Veraxa Biotech is trading 5.56% down now at $1.36 after extending declines from its August 27, 2026 close of $1.44; no credible company-specific announcement...
🔴 Veraxa Biotech is trading 11.59% down today with no identified company-specific catalyst
Veraxa Biotech is trading 11.59% down now at $1.45 after falling from its August 26 close of $1.64, with no credible company-specific announcement or filing...
🔴 Veraxa Biotech is trading 5.49% down today with no credible company-specific explanation
Veraxa Biotech is trading at $1.40, down 5.49%, with no credible company-specific announcement or filing dated August 27, 2026 explaining the decline. •...
🔴 Veraxa Biotech is trading 5.78% down today — no clear catalyst identified
Veraxa Biotech is trading 5.78% down at $1.63 on August 26, 2026, with no clear company-specific announcement or catalyst identified to explain the decline. -...
🔴 Veraxa Biotech is trading 10.26% down today amid broader biotech weakness
Veraxa Biotech is trading 10.26% down at $1.75 amid broader weakness across biotechnology shares. - The company announced positive early...
🔴 Veraxa Biotech is trading 7.69% down today amid broader biotech weakness
Veraxa Biotech is trading 7.69% down now at $1.80, amid broad weakness in biotechnology shares. - On August 24, 2026, Veraxa Biotech and Secarna...
🟢 Veraxa Biotech is trading 5.8% up today amid XBI's 2.02% gain
Veraxa Biotech is trading 5.8% up at $2.00, with the move most consistent with positive biotech-sector momentum. - The stock is outperforming its recent...
🟢 Veraxa Biotech rises 5.0% — Biotech Sector Surges on Positive mRNA Cancer Vaccine Trial Results
With Biotech (XBI) up 3.7%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, proxied by the XBI ETF, is trading...
🔴 Veraxa Biotech is trading 5.55% down today with no clear company-specific catalyst
Veraxa Biotech is trading 5.55% down at $1.88 after no clear company-specific catalyst emerged on August 10, 2026. - The company’s official news page shows...